Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03125928
Recruitment Status : Recruiting
First Posted : April 24, 2017
Last Update Posted : January 20, 2021
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Fox Chase Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2023